Literature DB >> 24563502

Standardizing scavenger receptor nomenclature.

Mercy Prabhudas1, Dawn Bowdish, Kurt Drickamer, Maria Febbraio, Joachim Herz, Lester Kobzik, Monty Krieger, John Loike, Terry K Means, Soren K Moestrup, Steven Post, Tatsuya Sawamura, Samuel Silverstein, Xiang-Yang Wang, Joseph El Khoury.   

Abstract

Scavenger receptors constitute a large family of proteins that are structurally diverse and participate in a wide range of biological functions. These receptors are expressed predominantly by myeloid cells and recognize a variety of ligands, including endogenous and modified host-derived molecules and microbial pathogens. There are currently eight classes of scavenger receptors, many of which have multiple names, leading to inconsistencies and confusion in the literature. To address this problem, a workshop was organized by the U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health to help develop a clear definition of scavenger receptors and a standardized nomenclature based on that definition. Fifteen experts in the scavenger receptor field attended the workshop and, after extensive discussion, reached a consensus regarding the definition of scavenger receptors and a proposed scavenger receptor nomenclature. Scavenger receptors were defined as cell surface receptors that typically bind multiple ligands and promote the removal of non-self or altered-self targets. They often function by mechanisms that include endocytosis, phagocytosis, adhesion, and signaling that ultimately lead to the elimination of degraded or harmful substances. Based on this definition, nomenclature and classification of these receptors into 10 classes were proposed. The discussion and nomenclature recommendations described in this report only refer to mammalian scavenger receptors. The purpose of this article is to describe the proposed mammalian nomenclature and classification developed at the workshop and to solicit additional feedback from the broader research community.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24563502      PMCID: PMC4238968          DOI: 10.4049/jimmunol.1490003

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  77 in total

Review 1.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

2.  Type F scavenger receptor SREC-I interacts with advillin, a member of the gelsolin/villin family, and induces neurite-like outgrowth.

Authors:  Mami Shibata; Junko Ishii; Hiroyuki Koizumi; Norihito Shibata; Naoshi Dohmae; Koji Takio; Hideki Adachi; Masafumi Tsujimoto; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

3.  Deletion of the murine scavenger receptor CD68.

Authors:  Li Song; Carolyn Lee; Christian Schindler
Journal:  J Lipid Res       Date:  2011-05-13       Impact factor: 5.922

4.  Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions.

Authors:  P J Gough; D R Greaves; H Suzuki; T Hakkinen; M O Hiltunen; M Turunen; S Y Herttuala; T Kodama; S Gordon
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

5.  SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells.

Authors:  N R Webb; P M Connell; G A Graf; E J Smart; W J de Villiers; F C de Beer; D R van der Westhuyzen
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

6.  Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain.

Authors:  Takeshi Shimaoka; Takashi Nakayama; Kunio Hieshima; Noriaki Kume; Noriko Fukumoto; Manabu Minami; Kazutaka Hayashida; Toru Kita; Osamu Yoshie; Shin Yonehara
Journal:  J Biol Chem       Date:  2004-05-05       Impact factor: 5.157

7.  The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain.

Authors:  X Gu; B Trigatti; S Xu; S Acton; J Babitt; M Krieger
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

8.  Isolation of the thrombospondin membrane receptor.

Authors:  A S Asch; J Barnwell; R L Silverstein; R L Nachman
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease.

Authors:  Kim Wilkinson; Joseph El Khoury
Journal:  Int J Alzheimers Dis       Date:  2012-05-15

10.  The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.

Authors:  Mohamed Arredouani; Zhiping Yang; YaoYu Ning; Guozhong Qin; Raija Soininen; Karl Tryggvason; Lester Kobzik
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

View more
  55 in total

1.  Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases.

Authors:  Lidia Garcia-Bonilla; Laibaik Park; Costantino Iadecola
Journal:  Exp Neurol       Date:  2014-08-23       Impact factor: 5.330

2.  Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.

Authors:  Sherleen Xue-Fu Adamson; Zhoumeng Lin; Ran Chen; Lisa Kobos; Jonathan Shannahan
Journal:  Toxicol In Vitro       Date:  2018-05-05       Impact factor: 3.500

Review 3.  Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization.

Authors:  Jan F C Glatz; Joost J F P Luiken
Journal:  J Lipid Res       Date:  2018-04-07       Impact factor: 5.922

Review 4.  A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases.

Authors:  Aarti Rana; Mushtaq Ahmed; Abdur Rub; Yusuf Akhter
Journal:  Virulence       Date:  2015-06-24       Impact factor: 5.882

Review 5.  Class A1 scavenger receptors in cardiovascular diseases.

Authors:  Jingjing Ben; Xudong Zhu; Hanwen Zhang; Qi Chen
Journal:  Br J Pharmacol       Date:  2015-03-27       Impact factor: 8.739

6.  Equine Arteritis Virus Has Specific Tropism for Stromal Cells and CD8+ T and CD21+ B Lymphocytes but Not for Glandular Epithelium at the Primary Site of Persistent Infection in the Stallion Reproductive Tract.

Authors:  Mariano Carossino; Alan T Loynachan; Igor F Canisso; R Frank Cook; Juliana R Campos; Bora Nam; Yun Young Go; Edward L Squires; Mats H T Troedsson; Thomas Swerczek; Fabio Del Piero; Ernest Bailey; Peter J Timoney; Udeni B R Balasuriya
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 7.  Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift.

Authors:  Yasir N Jassam; Saef Izzy; Michael Whalen; Dorian B McGavern; Joseph El Khoury
Journal:  Neuron       Date:  2017-09-13       Impact factor: 17.173

8.  The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophages.

Authors:  Fabian C Verbij; Nicoletta Sorvillo; Paul H P Kaijen; Johana Hrdinova; Ivan Peyron; Rob Fijnheer; Anja Ten Brinke; Alexander B Meijer; Floris P J van Alphen; Timo K van den Berg; Jonas J H Graversen; Soren K Moestrup; Jan Voorberg
Journal:  Blood Adv       Date:  2017-01-16

9.  A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease.

Authors:  Mercy R PrabhuDas; Cynthia L Baldwin; Paul L Bollyky; Dawn M E Bowdish; Kurt Drickamer; Maria Febbraio; Joachim Herz; Lester Kobzik; Monty Krieger; John Loike; Benita McVicker; Terry K Means; Soren K Moestrup; Steven R Post; Tatsuya Sawamura; Samuel Silverstein; Robert C Speth; Janice C Telfer; Geoffrey M Thiele; Xiang-Yang Wang; Samuel D Wright; Joseph El Khoury
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

10.  Scavenger receptor function of mouse Fcγ receptor III contributes to progression of atherosclerosis in apolipoprotein E hyperlipidemic mice.

Authors:  Xinmei Zhu; Hang Pong Ng; Yen-Chun Lai; Jodi K Craigo; Pruthvi S Nagilla; Pooja Raghani; Shanmugam Nagarajan
Journal:  J Immunol       Date:  2014-07-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.